The impact of knowledge of HPV positivity on cytology triage in primary high-risk HPV screening

被引:8
作者
Aitken, Clare A. [1 ]
Holtzer-Goor, Kim M. [2 ]
Uyterlinde, Anne [3 ]
van den Brule, Adriaan J. C. [4 ]
van der Linden, Hans C. [4 ]
Huijsmans, Cornelis J. [4 ]
de Kok, Inge M. C. M. [1 ]
van Kemenade, Folkert J. [5 ]
机构
[1] Erasmus MC Univ Med Ctr, Dept Publ Hlth, Rotterdam, Netherlands
[2] Dutch Natl Inst Publ Hlth & Environm, Ctr Populat Screening, Bilthoven, Netherlands
[3] Facilitaire Samenwerking Bevolkingsonderzoeken, Utrecht, Netherlands
[4] Jeroen Bosch Hosp, Pathol DNA, Shertogenbosch, Netherlands
[5] Erasmus MC Univ Med Ctr, Dept Pathol, Rotterdam, Netherlands
关键词
hrHPV screening; cervical cytology; cervical cancer screening;
D O I
10.1177/0969141319864991
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Objective Several studies have shown that there is an upward shift in the classification of cervical cytology when high-risk human papillomavirus (hrHPV) status is known to be positive. The Netherlands implemented primary hrHPV screening with reflex cytology as the primary screening test in 2017. Prior to implementation of the new programme, we investigated whether knowledge of hrHPV status influences cytology rating. Methods Using a set of 200 cytology slides that had been previously tested, two pairs of cytotechnicians rated 100 slides per pair twice: first without knowledge of hrHPV status and then, after a wash-out period of two months, with knowledge of hrHPV status. Results We found that hrHPV positive slides were more likely to be rated up over the referral threshold (i.e. from negative for intraepithelial lesion or malignancy to atypical squamous cells of undetermined significance+) than hrHPV negative slides at the second review when hrHPV status was known (relative risk = 3.2; 95% confidence interval: 1.3-7.9). Conclusions If the same upward shift in ratings were to be observed in the national programme, it may have implications for referrals of women with low-grade lesions.
引用
收藏
页码:221 / 224
页数:4
相关论文
共 10 条
[1]   Prior knowledge of HPV status improves detection of CIN2+ by cytology screening [J].
Benoy, Ina H. ;
Vanden Broeck, Davy ;
Ruymbeke, Maya J. ;
Sahebali, Shaira ;
Arbyn, Marc ;
Bogers, Johannes J. ;
Temmerman, Marleen ;
Depuydt, Christophe E. .
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2011, 205 (06) :569.e1-569.e7
[2]   Informed Cytology for Triaging HPV-Positive Women: Substudy Nested in the NTCC Randomized Controlled Trial [J].
Bergeron, Christine ;
Giorgi-Rossi, Paolo ;
Cas, Frederic ;
Schiboni, Maria Luisa ;
Ghiringhello, Bruno ;
Dalla Palma, Paolo ;
Minucci, Dania ;
Rosso, Stefano ;
Zorzi, Manuel ;
Naldoni, Carlo ;
Segnan, Nereo ;
Confortini, Massimo ;
Ronco, Guglielmo .
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2015, 107 (02)
[3]   Knowledge of the HPV Status Biases Cytotechnologists' Interpretation of Pap Tests Originally Diagnosed as Negative for Intraepithelial Lesion or Malignancy [J].
Doxtader, Erika E. ;
Brainard, Jennifer A. ;
Underwood, Dawn ;
Chute, Deborah J. .
CANCER CYTOPATHOLOGY, 2017, 125 (01) :60-69
[4]  
Erasmus MC. PALGA, 2018, MON 2017 BEV BAARM
[5]  
Erasmus MC. PALGA, 2016, MON 2015 BEV BAARM
[6]   HPV Prevalence in the Dutch cervical cancer screening population (DuSC study): HPV testing using automated HC2, cobas and Aptima workflows [J].
Huijsmans, Cornelis Johannes Jacobus ;
Geurts-Giele, Willemina Rosalia Rita ;
Leeijen, Cindy ;
Hazenberg, Hendrikus Lambertus Cornelius Maria ;
van Beek, Jenneke ;
de Wild, Carola ;
van der Linden, Johannes Cornelis ;
van den Brule, Adrianus Johannes Christiaan .
BMC CANCER, 2016, 16
[7]   The Tahoe Study Bias in the Interpretation of Papanicolaou Test Results When Human Papillomavirus Status Is Known [J].
Moriarty, Ann T. ;
Nayar, Ritu ;
Arnold, Terry ;
Gearries, Lisa ;
Renshaw, Andrew ;
Thomas, Nicole ;
Souers, Rhona .
ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE, 2014, 138 (09) :1182-1185
[8]   HPV DNA testing with cytology triage in cervical cancer screening: Influence of revealing HPV infection status [J].
Richardson, Lyndsay Ann ;
El-Zein, Mariam ;
Ramanakumar, Agnihotram V. ;
Ratnam, Samuel ;
Sangwa-Lugoma, Ghislain ;
Longatto-Filho, Adhemar ;
Cardoso, Marly Augusto ;
Coutlee, Francois ;
Franco, Eduardo L. .
CANCER CYTOPATHOLOGY, 2015, 123 (12) :745-754
[9]   Effectiveness of two strategies to follow-up ASC-US and LSIL screening results in The Netherlands using repeat cytology with or without additional hrHPV testing: a retrospective cohort study [J].
Siebers, Albert G. ;
Arbyn, Marc ;
Melchers, Willem J. G. ;
van Kemenade, Folkert J. ;
Vedder, Judith E. M. ;
van der Linden, Hans ;
van Ballegooijen, Marjolein ;
Bekkers, Ruud L. M. ;
Bulten, Johan .
CANCER CAUSES & CONTROL, 2014, 25 (09) :1141-1149
[10]   Focused rescreening of NILM Pap slides from women 30 years of age with positive high risk HPV DNA: An enhanced quality control measure [J].
Sturgis, Charles D. ;
Schaaf, Michael R. ;
Tickman, Ronald J. .
DIAGNOSTIC CYTOPATHOLOGY, 2013, 41 (05) :399-403